期刊文献+

拉帕替尼与绿原酸联合应用抑制巨噬细胞M2型极化及抗乳腺癌转移的作用研究 被引量:6

Combination of lapatinib with chlorogenic acid inhibits breast cancer metastasis by suppressing macrophage M2 polarization
下载PDF
导出
摘要 目的:研究拉帕替尼与绿原酸联合应用对抑制巨噬细胞M2型极化的影响及其在乳腺癌转移中的作用。方法:采用IL-13建立巨噬细胞M2型极化的体外模型,流式细胞术检测拉帕替尼和绿原酸合用对巨噬细胞M2型表面标志物CD206的影响;实时定量PCR检测拉帕替尼和绿原酸合用对巨噬细胞M2型特异性基因表达的影响;采用自发乳腺癌且发生肺转移的MMTV—PyVT小鼠模型考察两药合用对乳腺癌肺转移的影响,观察肺转移灶组织HE染色结果并统计转移灶点数;免疫荧光法分析乳腺癌组织中巨噬细胞的M2型极化情况。结果:拉帕替尼与绿原酸合用能够有效抑制IL-13诱导的F4/80hiCD206hi细胞(即M2型巨噬细胞)增多[(42.17%±2.59%)与(61.15%±7.58%),P〈0.05];两药合用能明显下调由IL-13诱导的Yml基因的上调[(1.8±0.0)与(1.0±0.0),P〈0.05],且其作用比绿原酸单给药组强[(0.9±0.1)与(1.8±0.0),P〈0.051;拉帕替尼与绿原酸合用能显著减少小鼠肺转移灶点数[P〈0.05];两药合用与对照组比较能降低瘤内CD206阳性细胞所占巨噬细胞的比例I(6.08%±2.60%)与(29.04%±5.86%),P〈0.05]。结论:拉帕替尼与绿原酸的联合用药能有效抑制巨噬细胞的M2型极化以及乳腺癌的转移。 Objective: To determine the effect of the combination of lapatinib with chlorogenic acid on classical macrophage adopted in the study. M2 marker CD206. metastasis of breast cancer in mouse model. Methods: The M2 polarization model induced by interlukinl3 in vitro was Flow cytometric analysis was performed to detect the expression of The transcription of M2-associated genes was measured by RT-PCR. HE staining was used to analyze the metastatic nodes of breast cancer in lungs of MMTV-PyVT mice. Immunostaining analysis was used to detect the expression of related proteins in breast cancer. Results: The combination of lapatinib and chlorogenic acid inhibited the expression of CD206 induced by IL-13 [ (42.17%± 2.59% ) vs (61.15%±7.58% ) , P 〈0.05 ]. The combination more markedly suppressed expression of M2-associated gene Yml than lapatinib alone [ (0.9 ± 0.1 ) vs ( 1.8 ± 0.0), P 〈 0. 05 ]. The combination of lapatinib and chlorogenic acid significantly reduced metastatic nodes in lung [ P 〈 0.05 ], and also significantly decreased the percentage of CD206 + cells in breast cancer compared to controls [ (6.08% ± 2.60% ) vs ( 29.04%± 5.86% ), P 〈 0.05 ]. Conclusion: The combination of lapatinib and chlorogenic acid can effectively inhibit macrophage M2 polarization and metastasis of breast cancer.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2015年第5期493-499,共7页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省自然科学基金(LY14H310008) 浙江省教育厅科研项目(Y201226213)
关键词 乳腺肿瘤/药物疗法 肿瘤转移 脱氧胞苷/类似物和衍生物 脱氧胞苷/治疗应用 抗肿瘤药(中药)/治疗应用 绿原酸/治疗应用 巨噬细胞 白细胞介素13 Breast neoplasms/drug therapy Neoplasm metastasis Deoxycytidine/analogs & derivatives Deoxycytidine/therapeutic use Antineoplastic drugs (TCD)/therapeutic use Chlorogenic acid/therapeutic use Macrophages Interleukin-13
  • 相关文献

参考文献17

  • 1GAO H,CHAKRABORTY (;,LEE-LIM A P, et al.The BMP inhibitor Coco reactivates hreasi cancer cellsat lung metastatic sites[ J]. Cell,2012,150(4) :764-779. 被引量:1
  • 2QIAN B Z, POLLARD J W. New tricks formetastasis-associated macrophages [ J ]. BreastCancer Res, 2012,14(4) :316. 被引量:1
  • 3QIAN B Z, POLLARD J W. Macrophage diversityenhances tumor progression and metastasis[ J] . Cell,2010,141(1):39-51. 被引量:1
  • 4QJANBZ,LI J, ZHANG H, et al. CCI2 recruitsinflammatory monocytes to facililate hreast-tumourmetastasis[J]. Nature, 2011 ,475(7355) :222-225. 被引量:1
  • 5BISWAS S K, MANTOVAN1 A. Macrophage plasticityand interaction with lymphocyte subsets: cancer as aparadigm[J]. Nat Immunol, 2010,11(10):889-896. 被引量:1
  • 6LEWIS C E, POLLARD J W. Distinct role ofmacrophages in different tumor microenvironments [ J ] .Cancer Res,2006,66(2) :605-612. 被引量:1
  • 7SCHMIKDER A, MICHEL J, SCHONHAAR K, etal. Differentiation and gene expression profile oftumor-associated macrophages [ J J . Semin CancerBiol, 2012,22(4) :289-297. 被引量:1
  • 8LAWRENCE T, NATOLI G. Transcriptionalregulation of macrophage polarization: enablingdiversity with identity [J] . Nat Rev Immunol, 2011,11(11) :750-761. 被引量:1
  • 9RUFFELLB,AFFARA N I, COUSSENS L M.Differential macrophage programming in the tumormicroenvironment [ J ]. Trends Immunol, 2012, 33(3):119-126. 被引量:1
  • 10FALCHOOK G S, MOULDER S L, WHELER J J,et al. Dual HER2 inhibition in combination withanti-VEGF treatment is active in heavily pretreatedHER2-positive breast cancer [ J ]. Ann Oncol,2013,24(12) :3004-3011. 被引量:1

同被引文献76

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部